BOUNDLESS BIO, INC. (BOLD) Free cash flow 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$47.2MFY2025 · since FY2023: -$47.5M → -$47.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.2M | +25.5% |
| FY2024 | -$63.4M | -33.5% |
| FY2023 | -$47.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice